Quality White Papers & Case Studies
-
Practical Considerations For Aseptic Gowning In Contamination Control Strategies (CCS)
2/13/2026
Personnel remain the most significant contributor to contamination risk. Explore these practical considerations for your CCS to address complex interactions between operators and their environment
-
Digital Solutions Enhance Pharmaceutical Manufacturing Performance
2/6/2026
Personalised therapies and advanced technologies are reshaping manufacturing. Explore how intelligent automation can improve flexibility, strengthen data integrity, and accelerate production.
-
Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy
2/6/2026
The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.
-
Why Compliance-Driven CDMOs Win Sponsor Contracts
2/5/2026
Learn how digital maturity and compliance excellence are reshaping CDMO competitiveness, as well as strategies that strengthen performance and accelerate tech transfers.
-
Raise Your Standards With Downflow Booth Airflow Containment
1/30/2026
Ensure personnel safety during hazardous material handling by mastering airflow dynamics and containment screens. Learn to achieve low exposure levels through advanced HEPA filtration methods.
-
Advancing An Integrated Biopharma Workflow Strategy
1/30/2026
Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.
-
Enhancing Novel Developability Through Automated MS Analytics
1/29/2026
Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.
-
Transforming Development Through Mass Spectrometry Data Analysis
1/29/2026
Mass spectrometry is vital for understanding PTMs in modern biologics. Explore key challenges and how streamlined analysis can reveal deeper, more sensitive insights into biotherapeutic structure.
-
End-To-End Workflow Integration For Antibody Development
1/29/2026
Modern antibody discovery generates massive, fragmented datasets that slow collaboration and decision‑making. Examine how unified digital workflows streamline R&D and improve data quality.
-
Automating Mass Spectrometry Analysis To Accelerate Oligonucleotide Drug Development
1/29/2026
Oligonucleotide therapeutics demand precise and efficient analytical workflows. Explore how automated data processing offers a faster path to understanding metabolites and advancing development.